nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—ADRB2—ulcerative colitis	0.957	1	CbGaD
Alprenolol—Metipranolol—ADRB2—ulcerative colitis	0.00136	0.123	CrCbGaD
Alprenolol—Esmolol—ADRB2—ulcerative colitis	0.00108	0.0979	CrCbGaD
Alprenolol—Betaxolol—ADRB2—ulcerative colitis	0.000948	0.0862	CrCbGaD
Alprenolol—Atenolol—ADRB2—ulcerative colitis	0.00094	0.0854	CrCbGaD
Alprenolol—Penbutolol—ADRB2—ulcerative colitis	0.00094	0.0854	CrCbGaD
Alprenolol—Bisoprolol—ADRB2—ulcerative colitis	0.000916	0.0832	CrCbGaD
Alprenolol—Acebutolol—ADRB2—ulcerative colitis	0.000867	0.0788	CrCbGaD
Alprenolol—Oxprenolol—ADRB2—ulcerative colitis	0.000861	0.0782	CrCbGaD
Alprenolol—Metoprolol—ADRB2—ulcerative colitis	0.000732	0.0665	CrCbGaD
Alprenolol—Pindolol—ADRB2—ulcerative colitis	0.000678	0.0615	CrCbGaD
Alprenolol—Atenolol—ABCB1—ulcerative colitis	0.000428	0.0389	CrCbGaD
Alprenolol—Acebutolol—ABCB1—ulcerative colitis	0.000395	0.0359	CrCbGaD
Alprenolol—Propranolol—ADRB2—ulcerative colitis	0.00037	0.0336	CrCbGaD
Alprenolol—Metoprolol—ABCB1—ulcerative colitis	0.000334	0.0303	CrCbGaD
Alprenolol—Propranolol—ABCB1—ulcerative colitis	0.000168	0.0153	CrCbGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL10—ulcerative colitis	0.000114	0.00358	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000114	0.00357	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000114	0.00356	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000111	0.00348	CbGpPWpGaD
Alprenolol—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.00011	0.00344	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CCL20—ulcerative colitis	0.000106	0.0033	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CXCR1—ulcerative colitis	0.000104	0.00325	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CCL20—ulcerative colitis	0.000103	0.00323	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000102	0.0032	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CCL20—ulcerative colitis	0.000101	0.00316	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CCL20—ulcerative colitis	0.000101	0.00314	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.0001	0.00313	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—ADRB2—ulcerative colitis	9.94e-05	0.00311	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	9.78e-05	0.00306	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—GNA12—ulcerative colitis	9.45e-05	0.00296	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CXCR2—ulcerative colitis	9.41e-05	0.00294	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	9.36e-05	0.00293	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CXCR2—ulcerative colitis	9.2e-05	0.00288	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	9.16e-05	0.00287	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CCL20—ulcerative colitis	9.13e-05	0.00286	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	9.05e-05	0.00283	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CXCR2—ulcerative colitis	9e-05	0.00282	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CXCR2—ulcerative colitis	8.96e-05	0.0028	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	8.96e-05	0.0028	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CCR6—ulcerative colitis	8.85e-05	0.00277	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CCR6—ulcerative colitis	8.65e-05	0.00271	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	8.65e-05	0.00271	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—GNA12—ulcerative colitis	8.58e-05	0.00269	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CCR6—ulcerative colitis	8.46e-05	0.00265	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CCR6—ulcerative colitis	8.42e-05	0.00264	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CXCR2—ulcerative colitis	8.13e-05	0.00255	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	7.97e-05	0.00249	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—ADCY5—ulcerative colitis	7.91e-05	0.00248	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—PTGER4—ulcerative colitis	7.79e-05	0.00244	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	7.75e-05	0.00243	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CCR6—ulcerative colitis	7.65e-05	0.00239	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—PTGER4—ulcerative colitis	7.62e-05	0.00238	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SEL1L—ulcerative colitis	7.46e-05	0.00233	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—PTGER4—ulcerative colitis	7.45e-05	0.00233	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—PTGER4—ulcerative colitis	7.41e-05	0.00232	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	7.41e-05	0.00232	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—GHRL—ulcerative colitis	7.13e-05	0.00223	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—GHRL—ulcerative colitis	6.97e-05	0.00218	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—GHRL—ulcerative colitis	6.82e-05	0.00213	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CXCR1—ulcerative colitis	6.79e-05	0.00213	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—GHRL—ulcerative colitis	6.79e-05	0.00212	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—PTGER4—ulcerative colitis	6.73e-05	0.00211	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CXCR1—ulcerative colitis	6.65e-05	0.00208	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CXCR1—ulcerative colitis	6.5e-05	0.00203	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	6.31e-05	0.00197	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	6.25e-05	0.00196	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCR1—ulcerative colitis	6.17e-05	0.00193	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—GHRL—ulcerative colitis	6.16e-05	0.00193	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCR1—ulcerative colitis	6.14e-05	0.00192	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCR1—ulcerative colitis	6.04e-05	0.00189	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	6e-05	0.00188	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CALM3—ulcerative colitis	5.97e-05	0.00187	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CCL20—ulcerative colitis	5.97e-05	0.00187	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—ADRB2—ulcerative colitis	5.9e-05	0.00185	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCR1—ulcerative colitis	5.9e-05	0.00185	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CCL20—ulcerative colitis	5.84e-05	0.00183	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CCL20—ulcerative colitis	5.71e-05	0.00179	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—ADRB2—ulcerative colitis	5.65e-05	0.00177	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—ADRB2—ulcerative colitis	5.62e-05	0.00176	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—GNA12—ulcerative colitis	5.61e-05	0.00175	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	5.59e-05	0.00175	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—GNA12—ulcerative colitis	5.49e-05	0.00172	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCL20—ulcerative colitis	5.42e-05	0.0017	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCL20—ulcerative colitis	5.39e-05	0.00169	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—GNA12—ulcerative colitis	5.36e-05	0.00168	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CXCR2—ulcerative colitis	5.32e-05	0.00166	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCL20—ulcerative colitis	5.3e-05	0.00166	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CXCR2—ulcerative colitis	5.2e-05	0.00163	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCL20—ulcerative colitis	5.18e-05	0.00162	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—ADRB2—ulcerative colitis	5.1e-05	0.0016	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—GNA12—ulcerative colitis	5.09e-05	0.00159	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CXCR2—ulcerative colitis	5.09e-05	0.00159	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—GNA12—ulcerative colitis	5.07e-05	0.00159	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CCR6—ulcerative colitis	5e-05	0.00156	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—GNA12—ulcerative colitis	4.98e-05	0.00156	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CCR6—ulcerative colitis	4.89e-05	0.00153	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—GNA12—ulcerative colitis	4.87e-05	0.00152	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCR2—ulcerative colitis	4.83e-05	0.00151	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCR2—ulcerative colitis	4.81e-05	0.0015	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—CXCL8—ulcerative colitis	4.8e-05	0.0015	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CCR6—ulcerative colitis	4.78e-05	0.0015	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—ADCY5—ulcerative colitis	4.77e-05	0.00149	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCR2—ulcerative colitis	4.72e-05	0.00148	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCR2—ulcerative colitis	4.62e-05	0.00145	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCR6—ulcerative colitis	4.54e-05	0.00142	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCR6—ulcerative colitis	4.52e-05	0.00141	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—CXCL8—ulcerative colitis	4.5e-05	0.00141	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCR6—ulcerative colitis	4.44e-05	0.00139	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SEL1L—ulcerative colitis	4.43e-05	0.00138	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PTGER4—ulcerative colitis	4.4e-05	0.00138	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—TNF—ulcerative colitis	4.35e-05	0.00136	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCR6—ulcerative colitis	4.34e-05	0.00136	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—ADCY5—ulcerative colitis	4.33e-05	0.00136	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SEL1L—ulcerative colitis	4.33e-05	0.00135	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PTGER4—ulcerative colitis	4.31e-05	0.00135	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MAML2—ulcerative colitis	4.28e-05	0.00134	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SEL1L—ulcerative colitis	4.23e-05	0.00132	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PTGER4—ulcerative colitis	4.21e-05	0.00132	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—GHRL—ulcerative colitis	4.03e-05	0.00126	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PTGER4—ulcerative colitis	4e-05	0.00125	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PTGER4—ulcerative colitis	3.98e-05	0.00124	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—GHRL—ulcerative colitis	3.94e-05	0.00123	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PTGER4—ulcerative colitis	3.91e-05	0.00122	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—GHRL—ulcerative colitis	3.85e-05	0.00121	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PTGER4—ulcerative colitis	3.82e-05	0.0012	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	3.74e-05	0.00117	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	3.66e-05	0.00115	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—GHRL—ulcerative colitis	3.66e-05	0.00114	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCR1—ulcerative colitis	3.64e-05	0.00114	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—GHRL—ulcerative colitis	3.64e-05	0.00114	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	3.58e-05	0.00112	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—GHRL—ulcerative colitis	3.58e-05	0.00112	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCR1—ulcerative colitis	3.57e-05	0.00112	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CALM3—ulcerative colitis	3.54e-05	0.00111	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CALM3—ulcerative colitis	3.53e-05	0.0011	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL6—ulcerative colitis	3.51e-05	0.0011	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—GHRL—ulcerative colitis	3.5e-05	0.0011	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCR1—ulcerative colitis	3.49e-05	0.00109	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—RIPK2—ulcerative colitis	3.47e-05	0.00109	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CALM3—ulcerative colitis	3.47e-05	0.00108	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CALM3—ulcerative colitis	3.39e-05	0.00106	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—ADRB2—ulcerative colitis	3.34e-05	0.00104	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CHP1—ulcerative colitis	3.26e-05	0.00102	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL20—ulcerative colitis	3.2e-05	0.001	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—ADRB2—ulcerative colitis	3.19e-05	0.000998	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL20—ulcerative colitis	3.13e-05	0.00098	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL20—ulcerative colitis	3.06e-05	0.000958	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—ADRB2—ulcerative colitis	3.03e-05	0.000948	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ADRB2—ulcerative colitis	3.01e-05	0.000943	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GNA12—ulcerative colitis	3.01e-05	0.000941	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—JAK2—ulcerative colitis	2.97e-05	0.00093	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GNA12—ulcerative colitis	2.94e-05	0.000921	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—ADRB2—ulcerative colitis	2.9e-05	0.000907	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GNA12—ulcerative colitis	2.88e-05	0.000901	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCR2—ulcerative colitis	2.85e-05	0.000892	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CXCL8—ulcerative colitis	2.85e-05	0.000892	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—ADCY5—ulcerative colitis	2.83e-05	0.000886	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—DLD—ulcerative colitis	2.82e-05	0.000882	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCR2—ulcerative colitis	2.79e-05	0.000873	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CXCL8—ulcerative colitis	2.79e-05	0.000873	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—ADCY5—ulcerative colitis	2.77e-05	0.000867	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCR2—ulcerative colitis	2.73e-05	0.000854	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CXCL8—ulcerative colitis	2.73e-05	0.000853	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CXCL8—ulcerative colitis	2.71e-05	0.000849	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—ADCY5—ulcerative colitis	2.71e-05	0.000847	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—JAK2—ulcerative colitis	2.7e-05	0.000845	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCR6—ulcerative colitis	2.68e-05	0.000839	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCR6—ulcerative colitis	2.62e-05	0.000821	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—IL2—ulcerative colitis	2.59e-05	0.000812	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—ADCY5—ulcerative colitis	2.57e-05	0.000804	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCR6—ulcerative colitis	2.57e-05	0.000803	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ADCY5—ulcerative colitis	2.56e-05	0.000801	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAML2—ulcerative colitis	2.54e-05	0.000795	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—ADCY5—ulcerative colitis	2.51e-05	0.000787	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAML2—ulcerative colitis	2.49e-05	0.000778	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CXCL8—ulcerative colitis	2.46e-05	0.000771	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—ADCY5—ulcerative colitis	2.46e-05	0.000769	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAML2—ulcerative colitis	2.43e-05	0.000761	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PTGER4—ulcerative colitis	2.36e-05	0.000739	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL2—ulcerative colitis	2.36e-05	0.000737	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PTGER4—ulcerative colitis	2.31e-05	0.000723	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PTGER4—ulcerative colitis	2.26e-05	0.000707	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GHRL—ulcerative colitis	2.16e-05	0.000676	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GHRL—ulcerative colitis	2.11e-05	0.000662	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CALM3—ulcerative colitis	2.09e-05	0.000655	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GHRL—ulcerative colitis	2.07e-05	0.000647	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RIPK2—ulcerative colitis	2.06e-05	0.000645	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CALM3—ulcerative colitis	2.05e-05	0.000641	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RIPK2—ulcerative colitis	2.02e-05	0.000631	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CALM3—ulcerative colitis	2e-05	0.000627	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RIPK2—ulcerative colitis	1.97e-05	0.000617	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADRB2—ulcerative colitis	1.79e-05	0.00056	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—JAK2—ulcerative colitis	1.77e-05	0.000552	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—JAK2—ulcerative colitis	1.73e-05	0.00054	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADRB2—ulcerative colitis	1.71e-05	0.000536	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—JAK2—ulcerative colitis	1.69e-05	0.000528	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.61e-05	0.000504	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—JAK2—ulcerative colitis	1.6e-05	0.000502	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—JAK2—ulcerative colitis	1.6e-05	0.000499	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CXCL8—ulcerative colitis	1.58e-05	0.000493	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—JAK2—ulcerative colitis	1.57e-05	0.000491	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—RELA—ulcerative colitis	1.54e-05	0.000483	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CXCL8—ulcerative colitis	1.54e-05	0.000482	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—IL2—ulcerative colitis	1.54e-05	0.000482	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—JAK2—ulcerative colitis	1.53e-05	0.00048	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADCY5—ulcerative colitis	1.52e-05	0.000475	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—IL2—ulcerative colitis	1.51e-05	0.000471	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ADCY5—ulcerative colitis	1.49e-05	0.000465	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—IL2—ulcerative colitis	1.47e-05	0.000461	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCL8—ulcerative colitis	1.46e-05	0.000458	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCL8—ulcerative colitis	1.46e-05	0.000456	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADCY5—ulcerative colitis	1.45e-05	0.000455	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCL8—ulcerative colitis	1.43e-05	0.000448	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCL8—ulcerative colitis	1.4e-05	0.000438	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL2—ulcerative colitis	1.4e-05	0.000437	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL2—ulcerative colitis	1.39e-05	0.000435	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL6—ulcerative colitis	1.38e-05	0.000433	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL2—ulcerative colitis	1.37e-05	0.000428	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS1—ulcerative colitis	1.36e-05	0.000426	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL2—ulcerative colitis	1.34e-05	0.000418	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MMP9—ulcerative colitis	1.32e-05	0.000412	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NFKB1—ulcerative colitis	1.3e-05	0.000408	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CALM3—ulcerative colitis	1.23e-05	0.000384	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—STAT3—ulcerative colitis	1.17e-05	0.000366	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TGFB1—ulcerative colitis	1.09e-05	0.00034	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ABCB1—ulcerative colitis	9.54e-06	0.000298	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—JAK2—ulcerative colitis	9.47e-06	0.000296	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—JAK2—ulcerative colitis	9.26e-06	0.00029	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RELA—ulcerative colitis	9.17e-06	0.000287	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—JAK2—ulcerative colitis	9.06e-06	0.000283	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RELA—ulcerative colitis	8.97e-06	0.000281	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TP53—ulcerative colitis	8.93e-06	0.00028	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ADCY5—ulcerative colitis	8.9e-06	0.000278	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RELA—ulcerative colitis	8.77e-06	0.000274	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCL8—ulcerative colitis	8.64e-06	0.00027	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCL8—ulcerative colitis	8.45e-06	0.000265	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCL8—ulcerative colitis	8.27e-06	0.000259	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL2—ulcerative colitis	8.26e-06	0.000258	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL6—ulcerative colitis	8.22e-06	0.000257	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL6—ulcerative colitis	8.18e-06	0.000256	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL2—ulcerative colitis	8.08e-06	0.000253	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL6—ulcerative colitis	8.04e-06	0.000252	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL2—ulcerative colitis	7.9e-06	0.000247	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL6—ulcerative colitis	7.86e-06	0.000246	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MMP9—ulcerative colitis	7.82e-06	0.000245	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NFKB1—ulcerative colitis	7.73e-06	0.000242	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MMP9—ulcerative colitis	7.65e-06	0.000239	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NFKB1—ulcerative colitis	7.56e-06	0.000237	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MMP9—ulcerative colitis	7.48e-06	0.000234	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NFKB1—ulcerative colitis	7.4e-06	0.000231	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—STAT3—ulcerative colitis	6.95e-06	0.000217	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—STAT3—ulcerative colitis	6.8e-06	0.000213	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—STAT3—ulcerative colitis	6.65e-06	0.000208	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPARG—ulcerative colitis	6.64e-06	0.000208	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TGFB1—ulcerative colitis	6.44e-06	0.000202	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TGFB1—ulcerative colitis	6.3e-06	0.000197	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TGFB1—ulcerative colitis	6.16e-06	0.000193	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALB—ulcerative colitis	5.97e-06	0.000187	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TP53—ulcerative colitis	5.3e-06	0.000166	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS2—ulcerative colitis	5.22e-06	0.000163	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TP53—ulcerative colitis	5.19e-06	0.000162	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TP53—ulcerative colitis	5.07e-06	0.000159	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6—ulcerative colitis	4.85e-06	0.000152	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6—ulcerative colitis	4.75e-06	0.000149	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6—ulcerative colitis	4.64e-06	0.000145	CbGpPWpGaD
